Autism Speaks

Vanderbilt researchers Beth Malow, MD, MS, left, Maria Niarchou, PhD, and Lea Davis, PhD, hope to create a genetic risk profile of insomnia in autism spectrum disorder to better inform treatments.
November 7, 2019

Study explores genetic risk profiling of insomnia in autism

Vanderbilt researchers are studying how genes affect sleep and circadian disturbances in autism spectrum disorder (ASD) with a goal of creating a genetic risk profile of insomnia in ASD.

autism concept: puzzle
November 16, 2017

Study may point to new treatment approach for ASD

Using sophisticated genome mining and gene manipulation techniques, researchers at Vanderbilt University Medical Center (VUMC) have solved a mystery that could lead to a new treatment approach for autism spectrum disorder (ASD).

March 3, 2016

Study reveals possible ‘dimmer switch’ drug for Rett syndrome

Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit.

December 18, 2014

Autism Speaks lauds Camarata’s contributions, years of support

Stephen Camarata, Ph.D., professor of Hearing and Speech Sciences, has been honored by Autism Speaks, a national autism advocacy and research organization, for dedicated service.

puzzel pieces, autism
August 28, 2014

VU receives grant renewal from Autism Speaks

Autism Speaks is renewing Vanderbilt University as an Autism Treatment Network (ATN) site with a three-year, $420,000 grant.

July 31, 2014

Sanders named TRIAD’s new medical director

Kevin Sanders, M.D., assistant professor of Psychiatry and Pediatrics, has been named medical director for the Treatment and Research Institute for Autism Spectrum Disorders (TRIAD).